Off-label use of rituximab in dermatology: pemphigus treatment

• Main Authors: Lislaine Bomm (Author), Tainá Scalfoni Fracaroli (Author), João Luz Sodré (Author), Aline Bressan (Author), Alexandre Carlos Gripp (Author)
• Format: Book
• Published: Sociedade Brasileira de Dermatologia, 2013-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Since its approval in 1997 by the FDA (United States Food and Drug Administration), rituximab has been used for certain B-cell lymphomas and treatment-resistant rheumatoid arthritis. Nevertheless, over the past 14 years, many case reports have demonstrated the efficacy of off-label rituximab in seve...